Pronunciation: (I-duh-ROO-bih-sin HY-droh-KLOR-ide)
A drug used with other drugs to treat acute myelogenous leukemia (AML). It is also being studied in the treatment of other types of cancer. Idarubicin hydrochloride blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called 4-demethoxydaunorubicin and Idamycin.
Source: NCI Dictionary of Cancer TermsDate last modified: 2014-08-15Idarubicin Hydrochloride